What will 2D matrix coding achieve for the pharma industry?
Tony Cordrey is Vice President of European Strategic Operations at Accord Healthcare. Having been at the forefront of the Falsified Medicines Directive (FMD) rollout,...
Antimicrobial resistance: Innovation must go hand-in-hand with awareness
Paul Chapman discusses antimicrobial resistance and how innovation must go hand-in-hand with awareness to combat superbugs. A recent study from researchers at Glasgow Caledonian University warned...
How pharma can prepare for Brexit
John Leyden shares his basic steps for how pharma can prepare for Brexit. I realise that most of us, including me, are getting tired of...
Does the Falsified Medicines Directive go far enough across the supply chain?
As one of the largest health threats to populations around the world, falsified medicine has become a central focus of governments, agencies and pharmaceutical companies over...
An open letter to Matt Hancock
Claudia Rubin pens an open letter to Matt Hancock MP urging him to celebrate science and support its central and complex role in shaping...
How much progress has been made with the NHS Long Term Plan delivering integrated...
Steve How and Paul Midgley, of Wilmington Healthcare, track the progress of NHS England’s diverse local health economies in delivering integrated care.
The recently published...
The benefits of using data to personalise cancer care
Reform research A data-driven approach to personalised cancer care published today, finds that a more effective use of data could bring about much-needed improvements...
The coming storm in the pharma supply chain
Keith Bontrager was a pioneer in mountain bike design who famously spoke of a ‘value triangle’ when it came to bikes. “Strong, light, cheap...
Pharmacy’s role in vaccinations: Protecting the nation’s health
What is the pharmacy’s role in vaccinations? Flu is a major cause of harm to individuals, leading to around 16,000 attributable deaths last season (over...
How AI is making its way into pharma and healthcare
Will we see enhancements of AI in pharma and healthcare? Having read many insightful articles and spoken to several experts on how artificial intelligence (AI)...
Latest articles
NICE to work with GW Pharma on cannabidiol evaluation
NICE has announced its intention to work with GW Pharma to address the issues highlighted by its independent appraisal committee in its evaluation of...
NHS Spine marks five-year anniversary
NHS Spine is marking five years since it was brought in house by NHS Digital and run as an open source service for the...
Cyber threats in healthcare: What are the risks?
FireEye have released a new report detailing cyber threats facing the healthcare industry. The report focuses on the three types of threat most common in...
Popular articles
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...
UK’s first national medical cannabis pilot study launched
CBD and full spectrum cannabis oil brand, Cannuba, is supporting the UK’s first national pilot study for medical cannabis, Project TWENTY21, which launched earlier...
NHS England makes Roche’s Hemlibra® available on NHS
NHS England has made Roche's Hemlibra® available on NHS. It is to fund the “life-changing treatment” for thousands of people with severe Haemophilia, which...
Positive phase III study results for injectable HIV-treatment regimen
ViiV Healthcare has announced positive headline results from its global phase III ATLAS-2M study of the investigational, long-acting, injectable, 2-drug regimen (2DR) of ViiV...
Pancreatic Cancer Story: John William Street
Pancreatic cancer is the 10th most common cancer in the UK, with around 9600 people diagnosed each year. The disease has the lowest survival...